Human breast cancer susceptibility protein 1,BRCA-1 ELISA Kit

Contact us for 48 wells and bulk quote

Introducing the Human Breast Cancer Susceptibility Protein 1, BRCA-1 ELISA Kit, a cutting-edge solution designed to facilitate accurate and efficient detection of BRCA-1 protein levels in human breast cancer samples. This state-of-the-art kit is meticulously crafted to cater to the needs of researchers and clinicians alike, providing a reliable tool for the identification and assessment of breast cancer susceptibility.

The Human Breast Cancer Susceptibility Protein 1, BRCA-1 ELISA Kit boasts a comprehensive and user-friendly design, ensuring seamless integration into laboratory workflows. With its high sensitivity and specificity, this kit enables precise quantification of BRCA-1 protein levels, enabling researchers to gain valuable insights into the molecular mechanisms underlying breast cancer development and progression.

Featuring a robust and optimized assay protocol, the Human Breast Cancer Susceptibility Protein 1, BRCA-1 ELISA Kit guarantees reproducible and accurate results, minimizing experimental variability. Its advanced technology allows for the detection of even low levels of BRCA-1 protein, enabling early identification of breast cancer susceptibility and facilitating timely intervention strategies.

This ELISA kit is meticulously manufactured using top-quality materials and adheres to stringent quality control standards, ensuring exceptional performance and reliability. Its user-friendly format and clear instructions make it accessible to both seasoned researchers and novices in the field, promoting ease of use and reducing the likelihood of errors.

In summary, the Human Breast Cancer Susceptibility Protein 1, BRCA-1 ELISA Kit represents a pivotal advancement in breast cancer research, offering a comprehensive and reliable solution for the accurate detection and quantification of BRCA-1 protein levels. With its exceptional sensitivity, specificity, and user-friendly design, this kit empowers researchers and clinicians to unravel the intricate complexities of breast cancer susceptibility, ultimately paving the way for improved diagnostic and therapeutic strategies.